773 related articles for article (PubMed ID: 11061509)
1. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
[TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E
J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
Maghnie M; Salati B; Bianchi S; Rallo M; Tinelli C; Autelli M; Aimaretti G; Ghigo E
J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans.
Gianotti L; Ramunni J; Lanfranco F; Maccagno B; Giordano R; Broglio F; Maccario M; Muller EE; Ghigo E; Arvat E
J Endocrinol Invest; 2001 Feb; 24(2):67-71. PubMed ID: 11263473
[TBL] [Abstract][Full Text] [Related]
7. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa.
Gianotti L; Pincelli AI; Scacchi M; Rolla M; Bellitti D; Arvat E; Lanfranco F; Torsello A; Ghigo E; Cavagnini F; Müller EE
J Clin Endocrinol Metab; 2000 Aug; 85(8):2805-9. PubMed ID: 10946886
[TBL] [Abstract][Full Text] [Related]
9. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
Procopio M; Maccario M; Grottoli S; Oleandri SE; Boffano GM; Camanni F; Ghigo E
Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.
Ghigo E; Goffi S; Nicolosi M; Arvat E; Valente F; Mazza E; Ghigo MC; Camanni F
J Clin Endocrinol Metab; 1990 Dec; 71(6):1481-5. PubMed ID: 2229304
[TBL] [Abstract][Full Text] [Related]
11. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
[TBL] [Abstract][Full Text] [Related]
12. Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine.
Broglio F; Benso A; Gottero C; Vito LD; Aimaretti G; Fubini A; Arvat E; Bobbio M; Ghigo E
Eur J Endocrinol; 2000 Feb; 142(2):157-63. PubMed ID: 10664524
[TBL] [Abstract][Full Text] [Related]
13. Effect of IGF-I administration on growth hormone secretion in obese subjects.
Tassone F; Gianotti L; Lanfranco F; Ganzaroli C; Oleandri SE; Taliano M; Muller EE; Ghigo E; Maccario M
Int J Obes Relat Metab Disord; 2001 May; 25 Suppl 1():S41-2. PubMed ID: 11466586
[TBL] [Abstract][Full Text] [Related]
14. Age and secretagogue type jointly determine dynamic growth hormone responses to exogenous insulin-like growth factor-negative feedback in healthy men.
Veldhuis JD; Weltman JY; Weltman AL; Iranmanesh A; Muller EE; Bowers CY
J Clin Endocrinol Metab; 2004 Nov; 89(11):5542-8. PubMed ID: 15531509
[TBL] [Abstract][Full Text] [Related]
15. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency.
Colao A; Cerbone G; Pivonello R; Aimaretti G; Loche S; Di Somma C; Faggiano A; Corneli G; Ghigo E; Lombardi G
J Clin Endocrinol Metab; 1999 Apr; 84(4):1277-82. PubMed ID: 10199767
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan.
Valetto MR; Bellone J; Baffoni C; Savio P; Aimaretti G; Gianotti L; Arvat E; Camanni F; Ghigo E
Eur J Endocrinol; 1996 Nov; 135(5):568-72. PubMed ID: 8980159
[TBL] [Abstract][Full Text] [Related]
17. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
Aimaretti G; Baffoni C; Bellone S; Di Vito L; Corneli G; Arvat E; Benso L; Camanni F; Ghigo E
J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
[TBL] [Abstract][Full Text] [Related]
18. Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa.
Gianotti L; Rolla M; Arvat E; Belliti D; Valetto MR; Ferdeghini M; Ghigo E; Müller EE
Biol Psychiatry; 1999 Feb; 45(3):334-9. PubMed ID: 10023511
[TBL] [Abstract][Full Text] [Related]
19. GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset.
Maghnie M; Cavigioli F; Tinelli C; Autelli M; Aricò M; Aimaretti G; Ghigo E
J Clin Endocrinol Metab; 2002 Jun; 87(6):2740-4. PubMed ID: 12050243
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval.
Darzy KH; Aimaretti G; Wieringa G; Gattamaneni HR; Ghigo E; Shalet SM
J Clin Endocrinol Metab; 2003 Jan; 88(1):95-102. PubMed ID: 12519836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
